Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

Adjuvant Therapies for Supratentorial Low-Grade Gliomas in Children

This page was last updated on January 25th, 2023

The ideal treatment for LGGs is complete surgical resection. However, this may not always be possible. When there is residual tumor or the location does not allow more than a biopsy, further treatment is controversial. Some tumors progress very quickly, others grow more slowly, others remain stable for many years, and others may even regress without treatment. Consequently, management should consider both treatment of symptoms and long-term control of the tumor as the child grows.


Radiotherapy may cause cognitive and/or endocrinological alterations, radionecrosis, or malignant changes (17). The problem is deciding when to give radiotherapy, what the effective dose will be for the type of LGG being treated, and how the patient will tolerate the treatment. The complications of radiotherapy are related to age and volume of brain radiated, with younger children having higher morbidity rates. Hence, in young children, chemotherapy is often preferred to radiotherapy (18).

  • Type of radiation: In newer types of radiotherapy, “focal or conformal” treatments are administered to LGGs without damage to neighboring cerebral tissue. Examples of such treatments are stereotactic radiotherapy, intensity-modulated radiotherapy (IMRT), image-guided radiotherapy, and proton-beam therapy (17). Stereotactic radiosurgery (a single, very elevated necrosing dose of radiation) has also been used to treat LGG recurrence.
  • Age limits for use of radiation: Radiotherapy is generally not used in patients younger than 3 years of age; and, unless there are no other options, radiotherapy is avoided up to the age of about 7 years. With the newer forms of conformal radiotherapy (including stereotactic radiotherapy) some consideration is being given to using focal radiotherapy in younger children (19).
  • Timing of radiotherapy or chemotherapy: Radiotherapy and chemotherapy are generally not recommended immediately after the complete or near complete resection of a tumor. In such patients, radiotherapy or chemotherapy is considered if the tumor recurs or progresses, often after further surgery. However, patients with unresectable tumors are considered for radiotherapy or chemotherapy immediately after surgery when there is a high risk for progression.


  • Temozolomide: The classic combination of procarbazine, lomustine (CCNU), and vincristine has been replaced by temozolomide due to its easy administration and reduced toxicity. When used as first-line treatment for LGGs, temozolomide has achieved good results in 31–61% of cases (20). Temozolomide has also been found to improve the prognosis in patients treated with radiotherapy (19).
  • Oligodendrogliomas: Excellent results (90%) have been obtained with procarbazine and temozolomide in the treatment of oligodendroglioma recurrence and in anaplastic oligodendrogliomas (19).

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.